Climb Bio, Inc.
CLYM
$1.21
-$0.02-1.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 98.06M | 150.92M | 193.35M | 223.14M | 105.03M |
| Total Receivables | 1.37M | 1.12M | 990.00K | -- | 2.02M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 622.00K | 722.00K | 737.00K | 2.16M | 594.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 230.00K | 2.11M | 2.53M | 696.00K | 1.58M |
| Total Current Assets | 100.28M | 154.87M | 197.61M | 226.00M | 109.22M |
|
|
|||||
| Total Current Assets | 100.28M | 154.87M | 197.61M | 226.00M | 109.22M |
| Net Property, Plant & Equipment | 451.00K | 490.00K | 12.00K | 21.00K | 111.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 226.00K | 215.00K | -- | -- | -- |
| Total Assets | 200.74M | 217.19M | 222.20M | 226.02M | 109.33M |
|
|
|||||
| Total Accounts Payable | 777.00K | 705.00K | 291.00K | 610.00K | 85.00K |
| Total Accrued Expenses | 6.10M | 4.04M | 2.33M | 2.77M | 2.30M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 155.00K | 157.00K | 58.00K | 100.00K | 225.00K |
| Total Finance Division Other Current Liabilities | -- | 31.00K | 744.00K | 265.00K | 337.00K |
| Total Other Current Liabilities | -- | 31.00K | 744.00K | 265.00K | 337.00K |
| Total Current Liabilities | 7.04M | 4.93M | 3.42M | 3.74M | 2.95M |
|
|
|||||
| Total Current Liabilities | 7.04M | 4.93M | 3.42M | 3.74M | 2.95M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 319.00K | 375.00K | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.36M | 5.31M | 3.42M | 3.74M | 2.95M |
|
|
|||||
| Common Stock & APIC | 443.76M | 441.73M | 440.04M | 434.84M | 264.06M |
| Retained Earnings | -250.66M | -229.88M | -221.46M | -212.57M | -157.68M |
| Treasury Stock & Other | 286.00K | 23.00K | 201.00K | -- | -- |
| Total Common Equity | 193.39M | 211.88M | 218.78M | 222.28M | 106.38M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 193.39M | 211.88M | 218.78M | 222.28M | 106.38M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 193.39M | 211.88M | 218.78M | 222.28M | 106.38M |
|
|
|||||